NOVARTIS INDIA
Back to Cashflow Statement
|
NOVARTIS INDIA Last 5 Year Cash Flow from Financing Activities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹-64 Cr | ₹-121 Cr | ₹-30 Cr | ₹-36 Cr | ₹-37 Cr |
What is the latest Cash Flow from Financing Activities ratio of NOVARTIS INDIA ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2025 | ₹-64 Cr |
| Mar2024 | ₹-121 Cr |
| Mar2023 | ₹-30 Cr |
| Mar2022 | ₹-36 Cr |
| Mar2021 | ₹-37 Cr |
How is Cash Flow from Financing Activities of NOVARTIS INDIA Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-64 Cr | Negative | |
| Mar2024 | ₹-121 Cr | Negative | |
| Mar2023 | ₹-30 Cr | Negative | |
| Mar2022 | ₹-36 Cr | Negative | |
| Mar2021 | ₹-37 Cr | - | |
Compare Cash Flow from Financing Activities of peers of NOVARTIS INDIA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NOVARTIS INDIA | ₹1,977.9 Cr | 2.6% | 1.7% | -8.1% | Stock Analytics | |
| ADANI ENTERPRISES | ₹253,411.0 Cr | -4.7% | -11.8% | -19.4% | Stock Analytics | |
| REDINGTON | ₹19,560.0 Cr | -3.4% | -8.9% | 14.6% | Stock Analytics | |
| MMTC | ₹9,646.5 Cr | -1.4% | 11.8% | -10.6% | Stock Analytics | |
| HONASA CONSUMER | ₹8,845.2 Cr | -2.3% | -1.2% | 9.8% | Stock Analytics | |
| LLOYDS ENTERPRISES | ₹8,263.2 Cr | 0.4% | -19.9% | -2.9% | Stock Analytics | |
NOVARTIS INDIA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NOVARTIS INDIA | 2.6% |
1.7% |
-8.1% |
| SENSEX | -1.7% |
-4.3% |
6.2% |
You may also like the below Video Courses